Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors

Vaccine

Volumn 27, Issue 6, 2009, Pages 882-887

  Lu, Peng jun ^a   Euler, Gary L ^a   Jumaan, Aisha O ^a   Harpaz, Rafael ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adult; Coverage; Herpes zoster; HZ vaccine; Vaccination

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADULT; ADVISORY COMMITTEE; AGED; ARTICLE; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HEALTH SERVICE; HERPES ZOSTER; HUMAN; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; UNITED STATES; VACCINATION;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; MALE; MIDDLE AGED; UNITED STATES; VACCINATION;

EID: 58249122600     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.077     Document Type: Article

References (51)

1. Oxman M.N. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 45 (1995) S41-S46
2. Gnann Jr. J.W., and Whitely R.J. Herpes zoster. N Engl J Med 347 (2002) 340-346
3. Katz J., Copper E.M., Walther R.R., Sweeney E.W., and Dworkin R.H. Acute pain in herpes zoster and its impact on health related quality of life. Clin Infect Dis 39 (2004) 342-348
4. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), Saunders, Philadelphia 783-823
5. Jung B.F., Johnson R.W., Griffin D.R.J., and Dworkin R.H. Risk factors for postherptic neuralgia in patients with herpes zoster. Neurology 62 (2004) 1545-1551
6. Bowsher D. The life time occurrence of herpes zoster and prevalence of postherptic neuralgia: a restrospective survey in an elderly population. Eur J Pain 3 (1999) 335-342
7. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., and Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82 November (11) (2007) 1341-1349
8. Soni A, Hill SC. Average annual health care use and expenses for Hz among the U.S. civilian noninstitutionalized population, 2003-2005. Statistical Brief #194. Agency for Healthcare Research and Quality, Rockville, MD; December 2007. http://www.meps.ahrq.gov/papers/st194/stat194.pdf.
9. Oxman M.N., Levin M.L., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherptic neuralgia in older adults. N Engl Med 352 (2005) 2271-2284
10. Pellissier J.M., Brisson M., and Levin M.J. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherptic neuralgia in older adults. Vaccine 25 (2007) 8326-8337
11. Hornberger J., and Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherptic neuralgia in older adults. Ann Intern Med 145 (2006) 317-325
12. Rothberg M.B., Virapongse A., and Smith K.J. Cost-effectiveness of a vaccine to prevent herpes zoster and postherptic neuralgia in older adults. Clin Infect Dis 44 (2007) 1280-1288
13. Centers for Disease Control and Prevention (CDC). Proposed recommendations and ACIP vote on use of zoster vaccine, 2006. Available at: http://www.cdc.gov/vaccines/recs/acip/downloads/min-ct06.rtf.
14. Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 57 05 (2008) 1-30
15. Singleton J.A., Santibanez T.A., and Wortley P.M. Influenza and pneumococcal vaccination of adults aged ≥65 years-racial/ethnic differences. Am J Prev Med 29 5 (2005) 412-420
16. 2007 NIS-Adult methodology report, National Immuniozation Survey. Reported by National Opinion Research Center (NORC) at the University of Chicago. 2008; January: 1-73.
17. Ezzati-Rice T.M., Frankel M.R., Hoaglin D.C., Loft J.D., Coronado V.G., and Wright R.A. An alternative measure of response rate in random-digit-dialing surveys that screen for eligible subpopulations. J Econ Soc Meas 26 (2000) 99-109
18. Korn E.L., and Graubard B.I. Predictive margins (direct standardization). Analysis of health surveys (1999), John Wiley & Sons, Inc., New York, NY pp. 126-140
19. Nadel M.R., Shapiro J.A., Klabunde C.N., Seeff L.C., Uhler R., Smith R.A., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 142 (2005) 86-94
20. Centers for Disease Control and Prevention (CDC). National, State, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1997. MMWR 47 26 (1998) 547-554
21. Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1987-1993. MMWR 43 08 (1994) 144-148
22. Centers for Disease Control and Prevention (CDC). Rotavirus vaccination coverage and adherence to the advisory committee on immunization practices (ACIP)-recommended vaccination schedule-United States, February 2006-May 2007. MMWR 57 15 (2008) 398-401
23. Lu P., Bridges C.B., Euler G.L., and Singleton J.A. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine 26 (2008) 1786-1793
24. Hinman A.R., and Orenstein W.A. Adult immunization: what can we learn from the childhood immunization program?. Clin Infect Dis 44 (2007) 1532-1535
25. Nichol K.L., MacDonald R., and Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 11 (1996) 673-677
26. Centers for Disease Control and Prevention (CDC). Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations-United States, 1996. MMWR 48 39 (1999) 886-890
27. National Foundation for Infectious Diseases (NFID) 2008. National survey on adult vaccination reports low consumer awareness of vaccines and the risks of vaccine-preventable diseases. Available at: http://www.nfid.org/pdf/factsheets/survey.pdf [accessed June 26, 2008].
28. Hurley L.P., Harpaz R., Daley M.F., Crane L.A., Beaty B.L., Barrow J., et al. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis 197 March (Suppl. 2) (2008) S216-S223
29. Orenstein W.A., Mootrey G.T., Pazol K., and Hinman A.R. Financing immunization of adults in the United States. Clin Pharmacol Ther 82 December (6) (2007) 764-768
30. O'Malley A.S., and Forrest C.B. Immunization disparities in older Americans: determinants and future research needs. Am J Prev Med 31 (2006) 150-158
31. Task Force on Community Preventive Services. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults-a report on recommendations from the Task Force on Community Preventive Services. MMWR Recomm Rep 48 RR-8 (1999) 1-15
32. ®, Merck's Shingles Vaccine for all Appropriate Adults Aged 60 and Older. Available at http://www.merck.com/newsroom/press_releases/product/2008_0515.html [accessed July 1, 2008].
33. Medicare Payment Advisory Commission (MEDPAC). Report to the congress: promoting greater efficiency in Medicare; June 2007. Available at: http://www.medpac.gov/documents/Jun07_EntireReport.pdf [accessed July 1, 2008].
34. Centers for Disease Control and Prevention (CDC). Early release of selected estimates based on data from the 2007 National Health Interview. Available at: http://www.cdc.gov/nchs/about/major/nhis/released200806.htm#4 [accessed July 9, 2008].
35. National Center for Health Statistics (NCHS). Health, United States; 2005. Available at: http://www.cdc.gov/nchs/data/hus/hus05.pdf#088 [accessed July 1, 2008].
36. Chaves S. Update on Safety of Herpes Zoster Vaccine Advisory Committee on Immunization Practices Atlanta, GA, June 27, 28. Available at: http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun07/12-zoster-chavez.pdf [accessed June 27, 2008].
37. Donahue J.G., Choo P.W., Manson J.E., and Platt R. The incidence of herpes zoster. Arch Intern Med 155 (1995) 1605-1609
38. Jumaan A.O., Yu O., Jackson L.A., Bohlke K., Galil K., and Seward J.F. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 191 (2005) 2002-2007
39. Mullooly J.P., Riedlinger K., Chun C., Weinmann S., and Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 133 April (2) (2005) 245-253
40. Ragozzino M.W., Melton III L.J., Kurland L.T., Chu C.P., and Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine 61 (1982) 310-316
41. Insinga R.P., Itzler R.F., Pellisier J.M., Saddier P., and Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 8 (2005) 748-753
42. Donald R.M., Baken L., Nelson A., and Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 16 3 (1999) 173-177
43. Nichol K.L., Korn J.E., and Baum P. Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire. Am J Prev Med 7 4 (1991) 199-203
44. Hutchinson B.G. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can J Public Health 80 (1989) 271-275
45. Cheney C., and Ramsdell J.W. Effect of medical records' checklists on implementation of periodic health measures. Am J Med 83 (1987) 129-136
46. Cohen D.I., Littenberg B., Wetzel C., and Neuhauser D. Improving physician compliance with preventive medicine guidelines. Med Care 20 (1982) 1040-1045
47. Briss P.A., Rodewald L.E., Hinman A.R., Shefer A.M., Strikas R.A., Bernier R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults: The Task Force on Community Preventive Services. Am J Prev Med 18 (2000) 97-140
48. Gyorkos T.W., Tannenbaum T.N., Abrahamowicz M., Bédard L., Carsley J., Franco E.D., et al. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health 85 Suppl. 1 (1994) S14-30
49. Buffington J., Bell K.M., and LaForce F.M. A target-based model for increasing influenza immunizations in private practice. J Gen Intern Med 6 (1991) 204-209
50. Centers for Disease Control and Prevention (CDC). Assessing adult vaccination status at age 50 years. MMWR 44 (1995) 561-563
51. Centers for Disease Control and Prevention (CDC). Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation-a report of the National Vaccine Advisory Committee. MMWR 49 RR-1 (2000)